Neuroprotective Role of Antidiabetic Drug Metformin Against Apoptotic Cell Death in Primary Cortical Neurons
- 1.1k Downloads
Oxidative damage has been reported to be involved in the pathogenesis of diabetic neuropathy and neurodegenerative diseases. Recent evidence suggests that the antidiabetic drug metformin prevents oxidative stress-related cellular death in non-neuronal cell lines. In this report, we point to the direct neuroprotective effect of metformin, using the etoposide-induced cell death model. The exposure of intact primary neurons to this cytotoxic insult induced permeability transition pore (PTP) opening, the dissipation of mitochondrial membrane potential (ΔΨm), cytochrome c release, and subsequent death. More importantly, metformin, together with the PTP classical inhibitor cyclosporin A (CsA), strongly mitigated the activation of this apoptotic cascade. Furthermore, the general antioxidant N-acetyl-l-cysteine also prevented etoposide-promoted neuronal death. In addition, metformin was shown to delay CsA-sensitive PTP opening in permeabilized neurons, as triggered by a calcium overload, probably through its mild inhibitory effect on the respiratory chain complex I. We conclude that (1) etoposide-induced neuronal death is partly attributable to PTP opening and the disruption of ΔΨm, in association with the emergence of oxidative stress, and (2) metformin inhibits this PTP opening-driven commitment to death. We thus propose that metformin, beyond its antihyperglycemic role, can also function as a new therapeutic tool for diabetes-associated neurodegenerative disorders.
KeywordsCytochrome c release Etoposide Metformin Neuronal apoptosis Mitochondrial permeability transition pore
mitochondrial membrane potential
AMP-activated protein kinase
permeability transition pore
tetramethyl-rhodamine methyl ester
The authors are very grateful to Drs. Juan P. Bolanos and Nicolas Wiernsperger for a stimulating discussion and to Mrs. MC Alguero Martín for her helpful technical assistance in flow cytometry. This work was partially supported by the JCyL (Grant SA062/03; Spain), INSERM, and Merck.
- Barrett, L. E., Van Bockstaele, E. J., Sul, J. Y., Takano, H., Haydon, P. G., & Eberwine, J. H. (2006). Elk-1 associates with the mitochondrial permeability transition pore complex in neurons. Proceedings of the National Academy of Sciences of the United States of America, 103, 5155–5160.PubMedCrossRefGoogle Scholar
- Custodio, J. B., Cardoso, C. M., & Almeida, L. M. (2002). Thiol protecting agents and antioxidants inhibit the mitochondrial permeability transition promoted by etoposide: Implications in the prevention of etoposide-induced apoptosis. Chemico-Biological Interactions, 140, 169–184.PubMedCrossRefGoogle Scholar
- Gilman, C. P., Chan, S. L., Guo, Z., Zhu, X., Greig, N., & Mattson, M. P. (2003). p53 is present in synapses where it mediates mitochondrial dysfunction and synaptic degeneration in response to DNA damage, and oxidative and excitotoxic insults. Neuromolecular Medecine, 3, 159–172.CrossRefGoogle Scholar
- Pirart, J. (1977). Diabetes mellitus and its degenerative complications: A prospective study of 4,400 patients observed between 1947 and 1973. Diabetes & Metabolism, 3, 245–255.Google Scholar
- Rapin, J. R., Lamproglou, I., Jacques, V., & Leponcin, M. (1988). Effects of metformin on metabolic indices of cerebral and peripheral ischemia. Diabetes & Metabolism, 14(Suppl 4bis), 587–590.Google Scholar
- Schinzel, A. C., Takeuchi, O., & Huang, Z., et al. (2005). Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia. Proceedings of the National Academy of Sciences of the United States of America, 102, 12005–12010.PubMedCrossRefGoogle Scholar